12832 Article(s)
Pub. Date
#Total Relationship(s)
1 76932 Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet 1978 May 13 1
2 77725 Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep 1978 Apr 1
3 94197 [Therapy of non-Hodgkin lymphomas]. Z Gesamte Inn Med 1979 Jul 1 1
4 132786 [Adriamycin, cyclophosphamide, and 5-fluorouracil in the treatment of metastasizing breast cancer (author's transl)]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 1976 Jun 15 1
5 206337 CCNU-adriamycin therapy in bronchogenic carcinoma. Cancer 1978 May 1
6 364284 Improvement in complete response rate, duration of response and survival with adriamycin combination chemotherapy for non-Hodgkin lymphoma: a prognostic factor comparison of two regimens. Med Pediatr Oncol 1978 1
7 373915 Clinical, toxicological, and pharmacological studies of combination chemotherapy of adenocarcinoma with adriamycin and Baker's antifolate. Cancer Chemother Pharmacol 1978 3
8 455570 Evaluation of cardiac activity and pharmacokinetic analysis of 3H-adriamycin in patients pretreated with beta-methyldigoxin. Cancer Chemother Pharmacol 1979 1
9 476691 Quantitative models for growth inhibition of human leukemia cells by antitumor anthracycline derivatives. Cancer Res 1979 Sep 1
10 526938 Alterations of lactate dehydrogenase isoenzymes with subacute adriamycin toxicity. Cancer Treat Rep 1979 Nov-Dec 2
11 528271 Effects of adriamycin and X-rays on euoxic and hypoxic EMT-6 cells in vitro. Int J Radiat Oncol Biol Phys 1979 Aug 1
12 528363 Mechanism of action of the anthracycline anti-tumor antibiotics, doxorubicin, daunomycin and rubidazone: preferential inhibition of DNA polymerase alpha. J Antibiot (Tokyo) 1979 Oct 1
13 535135 Evaluation of early doxorubicin-induced cardiotoxicity by means of systolic time intervals. Cancer Chemother Pharmacol 1979 1
14 911351 Effect of daunomycin, adriamycin and its congener AD 32 on the activity of DNase I from bovine pancreas. Biochem Pharmacol 1977 Oct 15 1
15 975096 Effect of deoxyribonuclease on adriamycin-polynucleotide complexes. Cancer Res 1976 Sep 2
16 1271407 Cellular pharmocodynamics of several anthrocycline antibiotics. J Med Chem 1976 May 1
17 1279258 [Adjuvant chemotherapy with MVP-CAB (methotrexate, vincristine, cisplatinum, cyclophosphamide, adriamycin and bleomycin) for epithelial tumors of the upper urinary tract]. Nihon Hinyokika Gakkai Zasshi 1992 Oct 1
18 1280141 Doxorubicin inhibits differentiation and enhances expression of the helix-loop-helix genes Id and mTwi in mouse osteoblastic cells. Biochem Int 1992 Oct 1
19 1283520 Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma. AIDS 1992 Dec 1
20 1285922 Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells. J Korean Med Sci 1992 Sep 2
21 1292755 Synergistic antiproliferative effects of the combination of interleukin-1 alpha and doxorubicin against human melanoma cells. Oncol Res 1992 7
22 1296877 [The effect of superoxide dismutase and catalase on the delayed toxicity of doxorubicin]. Cardiologia 1992 Oct 5
23 1318109 Effect of atrial natriuretic factor on renal cGMP production in rats with adriamycin-induced nephrotic syndrome. J Am Soc Nephrol 1992 Apr 3
24 1324674 Studies on the molecular pharmacology of GR63178A. A novel pentacyclic pyrolloquinone anticancer drug. Biochem Pharmacol 1992 Aug 4 1
25 1325792 Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cells. Biochem Biophys Res Commun 1992 Aug 31 3
26 1326212 Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II. Acta Obstet Gynecol Scand 1992 Jul 1
27 1326307 Comparative studies on the effects of doxorubicin and differentiation inducing agents on B16 melanoma cells. Eur J Cancer 1992 1
28 1330347 Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits. Carcinogenesis 1992 Nov 2
29 1334113 Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs. Int J Cell Cloning 1992 Nov 1
30 1338282 Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinomas. Anticancer Res 1992 Nov-Dec 3
31 1348623 P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines. Br J Cancer 1992 Apr 1
32 1348862 Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype. Proc Natl Acad Sci U S A 1992 Apr 15 1
33 1349283 Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture. Eur J Biochem 1992 Apr 15 2
34 1349796 Further characterization of two distinct adriamycin-resistant sublines from LoVo human colon carcinoma cells. Anticancer Res 1992 Mar-Apr 1
35 1349797 A single 24h contact time with adriamycin provokes the emergence of resistant cells expressing the Gp 170 protein. Anticancer Res 1992 Mar-Apr 1
36 1352455 Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 1992 1
37 1352990 Modulation of P-glycoprotein phosphorylation and drug transport by sodium butyrate. Biochemistry 1992 Jul 21 1
38 1353119 Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 1992 Aug 5
39 1353189 Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON. Lancet 1992 Aug 1 1
40 1353703 Cytogenetic alterations associated with P-glycoprotein- and non-P-glycoprotein-mediated multidrug resistance in SW-1573 human lung tumor cell lines. Cancer Res 1992 Aug 15 2
41 1354408 Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. Acta Med Okayama 1992 Jun 1
42 1355336 Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. Gan To Kagaku Ryoho 1992 Jul 2
43 1356264 Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci U S A 1992 Sep 15 1
44 1356339 Overexpression of P-glycoprotein and alterations in topoisomerase II in P388 mouse leukemia cells selected in vivo for resistance to mitoxantrone. Biochem Pharmacol 1992 Sep 1 1
45 1356441 In archaebacteria, there is a doxorubicin efflux pump similar to mammalian P-glycoprotein. Biochim Biophys Acta 1992 Oct 5 1
46 1356622 Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. Cancer Res 1992 Nov 1 3
47 1357834 The value of immunohistochemical detection of P-glycoprotein in breast cancer before and after induction chemotherapy. Yonsei Med J 1992 Jun 1
48 1358410 Clinical significance of erbB-2 (HER-2/neu) protein. Cancer Invest 1992 1
49 1358437 A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. Cancer Res 1992 Dec 1 1
50 1358894 Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma. J Cancer Res Clin Oncol 1992 2